DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Cetuximab
Cetuximab
Cetuximab (IMC-C225—marketed under the name Erbitux) is a chimeric (mouse/human) monoclonal antibody, an epidermal growth factor receptor (EGFR) inhibitor, given by intravenous infusion for treatment of metastatic colorectal cancer and head and neck cancer.
Cetuximab - List of case studies
- Cancer of Colon with Metastases
-
The patient began chemotherapy with FOLFIRI + Cetuximab regime , which was completed. A CAT scan showed that the ... was stable. The patient was in weekly therapy with Cetuximab alone. A CAT scan showed pulmonary and hepatic PD . The ...
- Metastatic Heteroplasia of the Lung
-
cell carcinoma of the lung (NSCLC) . More specifically, Cetuximab has shown prolongation of survival in patients with NSCLC including ... controlled I would suggest considering the combination of Cetuximab and chemotherapy. Furthermore such a decision should be preceded by ...
- Rectal Carcinoma, Gastric Carcinoma, Metastases.
-
recognized by oncology practitioners. 3a) CETUXIMAB : Cetuximab could be combined with FOLFIRI (FOLCETUX study) (see the report of ...
- Drugs
-
Celexa Cellulose triacetate Cetrorelix Cetuximab Chantix Chemoembolization Chemotherapy ... Chemotherapy with CDDP Chemotherapy with FOLFIRI + Cetuximab regime Cialis Cialis (10-20 mg) Cipralex Ciproxin ...
- Multirelapse Squamed Carcinoma of the Skin
-
the administration of cisplatin, infusional 5FU and cetuximab. questions: ... g1 + 5-fluorouracil (600 mg/m2 ic) gg1-4 + weekly Cetuximab (400 mg/mq loading dose, followed by 250 mg/mq maintenance) - ...
- Treatments
-
Chemotherapy treatment Chemotherapy with FOLFIRI + Cetuximab regime Chromogranin A Chronic immunosuppressive therapy ...